循环肿瘤细胞：癌症生物学和转移的窗口。
Circulating tumor cells: a window into cancer biology and metastasis.
机构信息
Howard Hughes Medical Institute, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, United States.
出版信息
Curr Opin Genet Dev. 2010 Feb;20(1):96-9. doi: 10.1016/j.gde.2009.12.002. Epub 2010 Jan 12.
Abstract
The presence of circulating tumor cells (CTCs) accompanies tumor invasion into the bloodstream. Detection, monitoring, and molecular analysis of these rare cancer cells shed into blood will provide a powerful and noninvasive approach for the detection of early disease, assessing prognosis and therapeutic response in established cancers, and targeting metastatic precursor cells. We review current and emerging technologies for CTC isolation, with a focus on capture efficiency, purity, and viability of CTCs, and their potential clinical applications.
摘要
循环肿瘤细胞（CTCs）的存在伴随着肿瘤侵入血液。这些罕见的癌细胞进入血液后被检测、监测和分子分析，将为早期疾病的检测、评估已确诊癌症的预后和治疗反应以及靶向转移前体细胞提供一种强大且非侵入性的方法。我们综述了目前和新兴的 CTC 分离技术，重点关注 CTC 的捕获效率、纯度和活力，及其潜在的临床应用。
相似文献
1
Circulating tumor cells: a window into cancer biology and metastasis.
Curr Opin Genet Dev. 2010 Feb;20(1):96-9. doi: 10.1016/j.gde.2009.12.002. Epub 2010 Jan 12.
2
Capturing circulating tumor cells of hepatocellular carcinoma.
Cancer Lett. 2012 Dec 29;326(1):17-22. doi: 10.1016/j.canlet.2012.07.024. Epub 2012 Jul 25.
3
Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
Acc Chem Res. 2014 Oct 21;47(10):2941-50. doi: 10.1021/ar5001617. Epub 2014 Aug 11.
4
Methodology for the Isolation and Analysis of CTCs.
Adv Exp Med Biol. 2020;1220:45-59. doi: 10.1007/978-3-030-35805-1_4.
5
Technologies for Viable Circulating Tumor Cell Isolation.
Int J Mol Sci. 2022 Dec 15;23(24):15979. doi: 10.3390/ijms232415979.
6
Isolation of rare circulating tumour cells in cancer patients by microchip technology.
Nature. 2007 Dec 20;450(7173):1235-9. doi: 10.1038/nature06385.
7
Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
BMC Cancer. 2016 Aug 8;16:614. doi: 10.1186/s12885-016-2638-x.
8
[Circulating tumor cells: liquid biopsy].
Bull Cancer. 2014 Jan 1;101(1):17-23. doi: 10.1684/bdc.2014.1883.
9
Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.
Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S25-31. doi: 10.2119/molmed.2015.00149.
10
Selective isolation and noninvasive analysis of circulating cancer stem cells through Raman imaging.
Biosens Bioelectron. 2018 Apr 15;102:372-382. doi: 10.1016/j.bios.2017.11.049. Epub 2017 Nov 16.
引用本文的文献
1
Ena/VASP-EVH1 inhibition prevents chemotaxis and metastasis by blocking the EVH1-WAVE2 interaction.
Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2423512122. doi: 10.1073/pnas.2423512122. Epub 2025 Jun 25.
2
The radioactive Pd and Pd palladium bipyridyl-bisphosphonate complexes for radionuclide therapy of bone metastatic tumor cells.
RSC Adv. 2025 Jun 3;15(23):18501-18511. doi: 10.1039/d5ra02172c. eCollection 2025 May 29.
3
Targeting tumor-associated genes, immune response, and circulating tumor cells in intrahepatic cholangiocarcinoma: Therapeutic potential of Atractylodes lancea (Thunb.) DC.
PLoS One. 2025 May 13;20(5):e0323732. doi: 10.1371/journal.pone.0323732. eCollection 2025.
4
Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters.
Cancer Lett. 2025 Apr 1;614:217546. doi: 10.1016/j.canlet.2025.217546. Epub 2025 Feb 12.
5
Circulating Tumor Cells in Cancer Diagnosis, Therapy, and Theranostics Applications: An Overview of Emerging Materials and Technologies.
Curr Pharm Des. 2025;31(9):674-690. doi: 10.2174/0113816128328459241009191933.
6
A randomized trial of aerobic exercise in colorectal cancer: Rationale, design, recruitment, and exercise adherence results.
Contemp Clin Trials. 2024 Nov;146:107702. doi: 10.1016/j.cct.2024.107702. Epub 2024 Oct 1.
7
Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.
Front Immunol. 2023 Dec 22;14:1326097. doi: 10.3389/fimmu.2023.1326097. eCollection 2023.
8
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
Cancers (Basel). 2023 Jul 15;15(14):3630. doi: 10.3390/cancers15143630.
9
Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics.
Nutrients. 2023 Apr 26;15(9):2088. doi: 10.3390/nu15092088.
10
Precision Medicine to Treat Urothelial Carcinoma-The Way Forward.
Cancers (Basel). 2023 Jun 1;15(11):3024. doi: 10.3390/cancers15113024.
本文引用的文献
1
The basics of epithelial-mesenchymal transition.
J Clin Invest. 2009 Jun;119(6):1420-8. doi: 10.1172/JCI39104.
2
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.
Lancet Oncol. 2009 Mar;10(3):233-9. doi: 10.1016/S1470-2045(08)70340-1. Epub 2009 Feb 11.
3
Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells.
Biotechnol Bioeng. 2009 Feb 1;102(2):521-34. doi: 10.1002/bit.22066.
4
Detection of mutations in EGFR in circulating lung-cancer cells.
N Engl J Med. 2008 Jul 24;359(4):366-77. doi: 10.1056/NEJMoa0800668. Epub 2008 Jul 2.
5
Isolation of rare circulating tumour cells in cancer patients by microchip technology.
Nature. 2007 Dec 20;450(7173):1235-9. doi: 10.1038/nature06385.
6
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Clin Cancer Res. 2007 Dec 1;13(23):7053-8. doi: 10.1158/1078-0432.CCR-07-1506.
7
[Detection and quantification of circulating tumor cells in peripheral blood in patients with colon cancer].
Med Clin (Barc). 2007 Sep 15;129(9):333-4. doi: 10.1157/13109544.
8
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry.
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11760-5. doi: 10.1073/pnas.0703875104. Epub 2007 Jun 29.
9
Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
J Chromatogr A. 2007 Aug 31;1162(2):154-61. doi: 10.1016/j.chroma.2007.05.064. Epub 2007 May 29.
10
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Clin Cancer Res. 2007 Apr 1;13(7):2023-9. doi: 10.1158/1078-0432.CCR-06-2701.
Zotero 插件